Skip to main content

Table 5 Postoperative pathological examination

From: Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

Variable

Patients, N (%)

Histologic grade (N = 22)

 G1. Well differentiated

0 (0)

 G2. Moderately differentiated

3 (13.6)

 G3. Poorly differentiated

18 (64.3)

 GX. Not evaluated

1 (4.6)

Pathological response (N = 22)

 Grade 0 (no effect)

0 (0)

 Grade I (slight effect)

16 (72.7)

 Grade I a (very slight effect)

7 (31.8)

 Grade I b (slight effect)

9 (40.9)

 Grade II (considerable effect)

5 (22.7)

 Grade III (complete response)

1 (4.6)